Haven't had much time lately? Here's what you may have missed in the last few months
The ESMO Tumour Portals allow you to find the key educational resources in your field of interest
17 Apr 2015
Anal pain and anal lesions may identify patients at risk of high-grade anal dysplasia for whom routine screening with high-resolution anoscopy could...
16 Apr 2015
Neither progression-free nor overall survival is improved in patients with gastrointestinal stromal tumours given first-line nilotinib compared with...
15 Apr 2015
Ramucirumab plus FOLFIRI boost overall survival for metastatic CRC patients who have failed bevacizumab and chemotherapy
14 Apr 2015
Masitinib plus gemcitabine increases overall survival for two subgroups of patients with pancreatic ductal adenocarcinoma compared with gemcitabine...
M. Preusser discusses the molecular markers that should be routinely assessed and Biomarker-driven algorithm for glioma treatment. Furthermore, he covers currently standardised molecular techniques, importance of quality control in molecular testing, and molecular markers that are currently under investigation in glioma and other primary brain tumours.